HIV is a public health priority and, with a broad range of individuals who could benefit from PrEP (Pre-Exposure Prophylaxis), the discussion about HIV prevention is crucial. Our goal is to empower providers to make conversations about PrEP a routine part of healthcare visits with the individuals in their practice, ensuring HIV prevention is prioritized.
COMMUNITY GUIDELINES/RULES OF ENGAGEMENT:
This space is intended for US healthcare professionals and is dedicated to fostering awareness and understanding of PrEP as an essential tool in HIV prevention. Please keep in mind that any posts or content on the TalkPrEP™ Linkedin account should not be considered as medical advice, consultations, diagnoses, or treatment recommendations.
TALK PREP, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc. All other marks referenced herein are the property of their respective owners.
©2025 Gilead Sciences, Inc. All rights reserved. US-UNBP-3502 06/25
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.talk-prep.com/
- Keywords
- Flowline Health.
Talkprep™ Questions
Talkprep™'s website is https://www.talk-prep.com/
Talkprep™'s LinkedIn profile is https://www.linkedin.com/company/talkprep
Talkprep™'s industry is
Pharmaceutical Manufacturing
Talkprep™'s categories are Pharmaceutical Manufacturing
